Chemical Component Summary

Name3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid
Identifiers3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid
FormulaC18 H15 N O3
Molecular Weight293.317
TypeNON-POLYMER
Isomeric SMILESc1ccc(cc1)c2c(oc(n2)CCC(=O)O)c3ccccc3
InChIInChI=1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)
InChIKeyOFPXSFXSNFPTHF-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count37
Chiral Atom Count0
Bond Count39
Aromatic Bond Count17

Drug Info: DrugBank

DrugBank IDDB00991 
NameOxaprozin
Groups approved
DescriptionOxaprozin is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID), used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis.
Synonyms
  • Oxaprozin potassium
  • Oxaprozinum
  • Oxaprozin
  • Oxaprozina
  • Oxaprozine
Brand Names
  • Apo-oxaprozin
  • Oxaprozin
  • Coxanto
  • Rhoxal-oxaprozin
  • Daypro
IndicationUsed to relieve the inflammation, swelling, stiffness, and joint pain associated with rheumatoid arthritis and osteoarthritis.
Categories
  • Acids, Acyclic
  • Agents causing hyperkalemia
  • Agents that produce hypertension
  • Analgesics
  • Analgesics, Non-Narcotic
ATC-CodeM01AE12
CAS number21256-18-8

Drug Targets

NameTarget SequencePharmacological ActionActions
Prostaglandin G/H synthase 1MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFG...unknowninhibitor
Prostaglandin G/H synthase 2MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL1071
PubChem 4614, 52326892
ChEMBL CHEMBL1071
ChEBI CHEBI:7822
CCDC/CSD OJUQAN, OJUQOB, OJURAO
COD 7224759